Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
British Journal of Pharmacology|May 6, 2008
DNAzymes and cardiovascular diseaseV L Benson, L M Khachigian, H C LoweJournal of Thrombosis and Haemostasis : JTH|July 15, 2006
DNAzymes targeting the transcription factor Egr-1 reduce myocardial infarct size following ischemia-reperfusion in ratsR Bhindi, L M Khachigian, H C LoweJournal of Thrombosis and Thrombolysis|April 3, 2007
sICAM-1 measurements are independent of processing method and sampling site in patients with coronary artery diseaseV L Benson, A C McMahon, H C LoweThe Journal of Biological Chemistry|August 7, 2001
Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2F S Santiago, H C Lowe, Y V Bobryshev, et al.Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
Vessel wall apoptosis and atherosclerotic plaque instabilityM M Kavurma, R Bhindi, H C Lowe, et al.The Journal of Invasive Cardiology|March 24, 2000
Intracoronary blood sampling using the multifunction probing catheter does not cause platelet activationH C Lowe, B Murray, B H Chong, et al.The American Journal of Pathology|March 18, 1999
Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2F S Santiago, H C Lowe, F L Day, et al.Internal Medicine Journal|October 17, 2002
Beyond angioplasty: novel developments in interventional cardiologyH C Lowe, D Burkoff, L M Khachigian, et al.Circulation Research|October 13, 2001
Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosisH C Lowe, R G Fahmy, M M Kavurma, et al.Annals of the New York Academy of Sciences|January 25, 2002
Catalytic oligonucleotides targeting EGR-1 as potential inhibitors of in-stent restenosisL M KhachigianPageof 8